These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37875315)

  • 1. Impact of a vaccine passport on first-dose SARS-CoV-2 vaccine coverage by age and area-level social determinants of health in the Canadian provinces of Quebec and Ontario: an interrupted time series analysis.
    Anato JLF; Ma H; Hamilton MA; Xia Y; Harper S; Buckeridge D; Brisson M; Hillmer MP; Malikov K; Kerem A; Beall R; Wagner CE; Racine É; Baral S; Dubé È; Mishra S; Maheu-Giroux M
    CMAJ Open; 2023; 11(5):E995-E1005. PubMed ID: 37875315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine equity: a retrospective population-based cohort study examining primary series and first booster coverage among persons with a history of immigration and other residents of Ontario, Canada.
    Wanigaratne S; Lu H; Gandhi S; Shetty J; Stukel TA; Piché-Renaud PP; Brandenberger J; Abdi S; Guttmann A
    Front Public Health; 2023; 11():1232507. PubMed ID: 37744516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysis.
    Maquiling A; Jeevakanthan A; Ho Mi Fane B
    Vaccine; 2023 May; 41(18):2932-2940. PubMed ID: 37019696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study.
    Shariff SZ; Richard L; Hwang SW; Kwong JC; Forchuk C; Dosani N; Booth R
    Lancet Public Health; 2022 Apr; 7(4):e366-e377. PubMed ID: 35278362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
    Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
    PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the impact of Quebec's vaccine lottery and vaccine passports on Covid-19 vaccination intention: Findings from repeated cross-sectional surveys.
    Dubé È; Dionne M; Rochette L
    Hum Vaccin Immunother; 2022 Nov; 18(6):2100168. PubMed ID: 35947802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
    Leigh Hobbs J; Paul LA; Buchan SA; Harris T; Wilson SE
    Vaccine; 2023 May; 41(21):3328-3336. PubMed ID: 37087395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papers Please - Predictive Factors of National and International Attitudes Toward Immunity and Vaccination Passports: Online Representative Surveys.
    Garrett PM; White JP; Dennis S; Lewandowsky S; Yang CT; Okan Y; Perfors A; Little DR; Kozyreva A; Lorenz-Spreen P; Kusumi T; Kashima Y
    JMIR Public Health Surveill; 2022 Jul; 8(7):e32969. PubMed ID: 35377317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces.
    Polisena J; Chen Y; Manuel D
    Vaccine; 2012 Mar; 30(11):1981-5. PubMed ID: 22245605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada.
    Drolet M; Deeks SL; Kliewer E; Musto G; Lambert P; Brisson M
    Vaccine; 2016 Apr; 34(16):1874-80. PubMed ID: 26954465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination mandates and vaccine uptake.
    Karaivanov A; Kim D; Lu SE; Shigeoka H
    Nat Hum Behav; 2022 Dec; 6(12):1615-1624. PubMed ID: 35654962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis.
    Bénard É; Drolet M; Laprise JF; Jit M; Prem K; Boily MC; Brisson M
    Lancet Glob Health; 2023 Jan; 11(1):e48-e58. PubMed ID: 36521952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Skowronski DM; Febriani Y; Ouakki M; Setayeshgar S; El Adam S; Zou M; Talbot D; Prystajecky N; Tyson JR; Gilca R; Brousseau N; Deceuninck G; Galanis E; Fjell CD; Sbihi H; Fortin E; Barkati S; Sauvageau C; Naus M; Patrick DM; Henry B; Hoang LMN; De Wals P; Garenc C; Carignan A; Drolet M; Jassem AN; Sadarangani M; Brisson M; Krajden M; De Serres G
    Clin Infect Dis; 2022 Nov; 75(11):1980-1992. PubMed ID: 35438175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020-October 2021.
    Murthy N; Saelee R; Patel Murthy B; Meng L; Shaw L; Gibbs-Scharf L; Harris L; Chorba T; Zell E
    Public Health Rep; 2023; 138(1):183-189. PubMed ID: 36129241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario.
    Smylie J; McConkey S; Rachlis B; Avery L; Mecredy G; Brar R; Bourgeois C; Dokis B; Vandevenne S; Rotondi MA
    CMAJ; 2022 Aug; 194(29):E1018-E1026. PubMed ID: 35918087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.
    Gagneur A; Quach C; Boucher FD; Tapiero B; De Wals P; Farrands A; Lemaitre T; Boulianne N; Sauvageau C; Ouakki M; Gosselin V; Gagnon D; Petit G; Jacques MC; Dubé È
    BMC Public Health; 2019 Feb; 19(1):160. PubMed ID: 30727991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.
    Schwalbe N; Nunes MC; Cutland C; Wahl B; Reidpath D
    J Urban Health; 2024 Apr; ():. PubMed ID: 38578336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.